☆ 4.0 Editorial Material

Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis

PEDIATRIC DERMATOLOGY (2019)

Journal

PEDIATRIC DERMATOLOGY

Volume 36, Issue 1, Pages 172-176

Publisher

WILEY

DOI: 10.1111/pde.13707

Keywords

adverse effects; atopic dermatitis; biologic; dupilumab; pediatric drug use

Funding

Saint Louis University

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0

Not enough ratings

Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis

Journal

PEDIATRIC DERMATOLOGY

Publisher

WILEY

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis

Journal

PEDIATRIC DERMATOLOGY

Publisher

WILEY

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper